The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
FDA plans possible black box warning for COVID-19 shots amid rare heart risk reports; studies say the virus carries a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback